PhotoMedex Covers XTRAC Laser Treatment Co-Pay for Children with Psoriasis

MONTGOMERYVILLE, Pa., Aug. 4, 2011 /PRNewswire/ -- PhotoMedex, Inc. (NASDAQ:
PHMD), an innovator of medical devices, today launches a co-pay reimbursement
offer* to assist the families of children who suffer from
psoriasis. In honor of the National
Psoriasis Awareness Month in August (and continuing through
November), children, who may not have been able to afford
treatments, will have their XTRAC® Excimer Laser (www.XTRACLaser.com) treatment
co-pays covered by PhotoMedex. All major insurance companies
reimburse for XTRAC laser treatments, and now with co-pays covered,
new hope is available for this underserved population.

For many children, the disease goes beyond the physical painful
red dry patches of scaly, thickened skin and can create emotional
scars. Nearly 50 percent of children with psoriasis report that
they have been bullied because of their disease. In a
National Psoriasis Foundation survey of children with psoriasis, 44
percent reported that they have been bullied by their peers, and 38
percent stated the abuse was a direct result of their psoriasis.
Of those bullied, 65 percent said it caused anxiety, and
nearly one-quarter had a decrease in academic performance.

About 20,000 children under the age of 10 are diagnosed with
psoriasis every year in the United States. The XTRAC laser
treatment provides relief from itching, redness and pain; without
the negative side-effects commonly associated with other
treatments, ranging from premature aging of healthy skin to the
risk of malignancies and tuberculosis. The XTRAC laser is the only
clinically proven, FDA-cleared, dermatology excimer laser with
independent safety and quality c